Semaglutide (Ozempic®, Wegovy® and related brands) — Patient-Friendly Guide (Australia)

Semaglutide is a widely used medicine for improving blood sugar control in type 2 diabetes and, in some people, for long-term weight management. It belongs to a class of medicines called GLP‑1 receptor agonists.

This guide explains what semaglutide does, how it works in the body, how it’s typically taken, what to expect, and key safety considerations—tailored for readers in Australia. Always follow the advice of your healthcare professional and the instructions provided with your specific product.

Basic product information

• Medicine name: Semaglutide
• Medicine type: GLP‑1 receptor agonist
• Common brands in Australia: Ozempic® (type 2 diabetes), Wegovy® (weight management, where approved/available)
• Administration: Subcutaneous injection (under the skin)
• Dosing frequency (typical): Usually once weekly (varies by product and titration schedule)
• What “titration” means: Dose is typically increased gradually to improve tolerability

Semaglutide may be supplied in prefilled injection devices depending on the brand. Your product packaging will indicate the strength and how to use the device correctly.

How semaglutide works (mechanism of action)

Semaglutide mimics the action of a naturally occurring hormone called GLP‑1 (glucagon-like peptide‑1). It acts on GLP‑1 receptors in the body, which helps influence appetite, blood sugar regulation, and gastric emptying.

• Improves blood sugar control: It increases glucose-dependent insulin secretion (the body releases insulin when needed) and reduces glucagon secretion after meals.
• Reduces appetite: It helps signal fullness in the brain, which can reduce overall calorie intake.
• Slows stomach emptying: This can reduce post-meal glucose spikes and may contribute to feeling full sooner.
• Supports weight management: By reducing appetite and food intake, it may help people lose weight over time.

Many people notice changes gradually rather than immediately. Early side effects—if they occur—often relate to the way the medicine affects digestion and appetite.

Pharmacokinetics (how semaglutide behaves in the body)

Pharmacokinetics describes how a medicine is absorbed, distributed, metabolised, and eliminated. Semaglutide is designed for long-lasting action, which is why weekly dosing is possible.

• Absorption: When injected under the skin, semaglutide is absorbed steadily.
• Half-life: Semaglutide has a long half-life, supporting once-weekly administration.
• Steady state: With consistent dosing, levels build up gradually and stabilise after repeated weekly doses.
• Metabolism: It is broken down through general protein metabolism pathways.
• Elimination: The body clears it mainly via metabolic processes; excretion pathways contribute as metabolites.

Because it remains in the body for a long time, missing doses may not cause an immediate drop in effect—however, it still matters to follow the recommended “missed dose” guidance for your specific product.

Typical uses in Australia

Semaglutide is used for two broad purposes, depending on the product and eligibility:

• Type 2 diabetes (blood sugar management): To improve glycaemic control as part of a broader treatment plan that may include diet, exercise, and other diabetes medicines.
• Weight management (in selected patients): For long-term weight management when used alongside lifestyle changes.

Individual suitability depends on medical history, other medications, and local prescribing/indication rules. Your healthcare professional can guide which product is appropriate for your goals.

Indications (what it is used to treat)

Indications differ by brand and strength. In Australia, semaglutide products are used for:

• Type 2 diabetes: as an adjunct to diet and exercise to improve glycaemic control (often with additional benefits such as weight reduction for some people).
• Chronic weight management: in individuals who meet criteria set for weight management therapy.

If you are unsure which semaglutide product aligns with your situation, check the product label and discuss options with your clinician.

Dosing and timing (what “once weekly” means)

Semaglutide is commonly taken once weekly. The correct dose and schedule depend on the product and your tolerance. Many regimens begin with a lower dose and increase stepwise (“titration”) to reduce gastrointestinal side effects.

Typical timing

• Choose a consistent day: Many people pick a day of the week they can remember.
• Use at about the same time: Exact timing is less critical than consistency, but sticking to a routine helps.
• Do not double up: If you miss a dose, follow the manufacturer’s instructions for that product.

Common titration approach (general concept)

The initial dose is usually lower and gradually increased. Your clinician may adjust the schedule based on side effects, blood sugar results, and weight goals.

• Start low: to allow your digestive system to adapt.
• Increase gradually: the goal is effective treatment with manageable side effects.
• Maintain a target dose: once the desired dose is tolerated.

Important: Always follow the dosing instructions provided with your specific semaglutide device and strength. Different products and strengths are not interchangeable.

Food interactions and what to expect with meals

Semaglutide affects gastric emptying and appetite, so the relationship with food can influence side effects and comfort. There are no “forbidden” foods, but practical meal strategies can help.

Recommended approach

• Eat smaller meals: you may feel full sooner.
• Choose slower, simpler meals: less volume and less greasy foods often feel better.
• Stay hydrated: especially if you experience nausea.
• Consider protein and fibre: balanced meals help support longer-lasting fullness.

Meal timing

• No strict requirement to take semaglutide with or without food.
• If you find that meals worsen nausea or reflux, try smaller portions and avoid large late dinners.

Glucose monitoring when eating

If semaglutide is used alongside other glucose-lowering medicines (particularly insulin or medicines that can cause hypoglycaemia), your clinician may recommend changes to reduce the risk of low blood sugar—especially when appetite changes and you eat less.

Alcohol and medicine interactions

Alcohol can affect blood sugar control, hydration, appetite, and stomach irritation—factors that can be particularly relevant when taking a medicine that slows digestion and may cause nausea.

• Hypoglycaemia risk: Alcohol may increase the risk of low blood sugar in some people (especially if meals are irregular or if combined with other diabetes medicines).
• Stomach effects: Alcohol can worsen nausea, reflux, gastritis, or vomiting in some individuals.
• Hydration: Alcohol can contribute to dehydration, which matters if you experience diarrhoea or vomiting.

In general, moderation is advisable. If you have diabetes or take other glucose-lowering therapy, discuss safe drinking practices with your healthcare professional.

Other medicine interactions (important)

Semaglutide may interact with other medicines indirectly because it slows gastric emptying and changes appetite. The most important interaction concerns glucose-lowering medicines.

Medicines that may require extra caution

• Insulin and medicines that can cause hypoglycaemia (low blood sugar):
• Sulfonylureas (e.g., gliclazide, glimepiride) may increase hypoglycaemia risk when combined.
• Oral medications requiring rapid absorption: slowing of gastric emptying could affect the speed of absorption for some tablets.
• Other weight-loss or appetite-modifying medicines: may increase side effects like nausea or poor oral intake.

Always provide your healthcare team with a full list of medicines (including over-the-counter products and supplements). For some combinations, dose adjustments or additional glucose monitoring may be recommended.

Safety profile: side effects and when to seek help

Like all medicines, semaglutide can cause side effects. Many people experience mild to moderate gastrointestinal symptoms, particularly during dose increases. Most improve as the body adapts.

Common side effects

• Nausea
• Vomiting
• Diarrhoea or constipation
• Abdominal discomfort, bloating, or indigestion
• Reduced appetite
• Heartburn or reflux symptoms
• Fatigue (in some people)

Less common but serious risks

These are not expected in most patients, but awareness is important. Seek urgent medical advice if symptoms are severe or concerning.

• Signs of pancreatitis: severe persistent abdominal pain (sometimes radiating to the back), with or without vomiting.
• Gallbladder problems: pain in the right upper abdomen, fever, or yellowing of skin/eyes.
• Dehydration: dizziness, fainting, very reduced urination—especially if vomiting or diarrhoea is ongoing.
• Hypoglycaemia (low blood sugar): sweating, shaking, confusion, palpitations, weakness—especially if combined with insulin or sulfonylureas.
• Allergic reactions: swelling of face/lips, difficulty breathing, rash or hives.

Who should be extra cautious

• People with a history of pancreatitis
• People with significant gastrointestinal disease that affects motility
• Those prone to dehydration
• People taking medicines that can cause hypoglycaemia

If you experience troublesome side effects, your healthcare professional may recommend adjusting the dose, slowing titration, or reviewing other medications.

Practical use tips (how to take semaglutide smoothly)

Injection basics

• Injection sites: commonly the abdomen, thigh, or upper arm (follow your product instructions).
• Rotate sites: helps reduce skin irritation.
• Use correct technique: take care with device handling and needle disposal as instructed.
• Store properly: adhere to cold-chain or temperature storage requirements on the package.

Managing nausea and indigestion

• Eat smaller portions and avoid large, fatty meals.
• Choose bland foods if nausea occurs.
• Stay hydrated (small sips can help).
• Avoid lying down right after eating if reflux happens.
• Discuss anti-nausea strategies with your clinician if symptoms persist.

Handling constipation

• Increase fluid intake.
• Aim for fibre-containing foods if tolerated.
• Maintain gentle physical activity if safe for you.
• Talk to your pharmacist about appropriate constipation relief options if needed.

When to consider temporary dose adjustments

Don’t stop or change the schedule on your own. If side effects are severe, persistent, or affect your ability to eat and drink, contact your healthcare professional for guidance.

Missed doses and missed timing

If you miss a dose, the correct action depends on how far you are from your scheduled injection day and the specific product. Always follow the “missed dose” instructions in your medicine’s Consumer Medicine Information (CMI) or device leaflet.

• General principle: take it as soon as you remember if it’s still close to your usual schedule.
• Spacing matters: do not take two doses too close together.
• Return to routine: resume your chosen day if advised.

Your pharmacist can help you interpret the missed dose instructions for your brand and strength.

Alternative options (if semaglutide isn’t suitable)

Depending on your goals (diabetes control, weight management, or both) and your medical history, other options may be available. Alternatives can include other GLP‑1 receptor agonists or related medicines, as well as different medication classes.

• Other GLP‑1 receptor agonists: examples include liraglutide and dulaglutide (availability and indications vary).
• Dual incretin therapies: some newer options combine GLP‑1 and GIP activity (where approved for relevant indications).
• Other weight-management medicines: options may include medicines with different mechanisms (criteria and suitability vary).
• Non-drug approaches: structured diet plans, supervised physical activity, behavioural support, and—where indicated—bariatric procedures.

The “best alternative” depends on factors such as your current diabetes medications, kidney and liver function, tolerance, and weight goals. Discuss options with your healthcare professional.

Market and legal context in Australia (high-level)

In Australia, medicines are regulated by the Therapeutic Goods Administration (TGA). Semaglutide products marketed in Australia must meet requirements for quality, safety, and performance. Product availability can vary by brand, strength, and supply conditions.

For consumers, the safest approach is to purchase from reputable Australian pharmacies and retailers that comply with Australian health and goods laws, provide clear product identification, and supply appropriate documentation.

Availability and brand supply can change over time due to manufacturing schedules, demand fluctuations, and regulatory updates. Your pharmacy can advise on current availability for specific strengths.

Recent guidance and practical updates (what to watch for)

Guidance around GLP‑1 medicines can evolve as new evidence emerges and prescriber protocols are updated. While this guide is designed to be broadly helpful, always check the most current information available through:

• Your product’s official leaflet/Consumer Medicine Information (CMI)
• Advice from your treating clinician
• Pharmacist guidance for dosing changes, supply alternatives, and side-effect management

If you have kidney disease, a history of pancreatitis, or take multiple glucose-lowering medicines, ongoing monitoring and tailored advice are especially important.

Delivery and availability (online pharmacy experience in Australia)

Availability of semaglutide products can vary by brand and dose strength. When ordering online:

• Confirm the exact strength and brand before payment.
• Check storage requirements on arrival and during handling.
• Allow for delivery timelines shown at checkout.
• Track your order if the courier service provides tracking.

If a specific dose is temporarily unavailable, your pharmacy may offer clinically appropriate alternatives or advise when restocking is expected. Availability should never compromise safety—ensure the product you receive matches your intended regimen.

Safety checklist before you start (or restart)

• Do you have a history of pancreatitis or significant gallbladder disease?
• Are you taking insulin or a medicine that can cause hypoglycaemia?
• Do you have frequent severe vomiting, dehydration risk, or bowel motility problems?
• Are you taking other medicines that may interact (including oral tablets you take at specific times)?
• Have you recently changed your diet or meal schedule?

If any of these points apply, discuss them with your healthcare professional before using semaglutide.

Summary table: key points at a glance

FAQ (Frequently asked questions)

1. Is semaglutide a tablet?

Most semaglutide products available for these indications are administered by subcutaneous injection. Use the specific device type provided with your brand.

2. When will I start seeing results?

Some people notice appetite changes within the first days to weeks. For weight and blood sugar improvements, meaningful changes typically occur over weeks to months, especially as doses are increased and stabilised.

3. Why do I need a lower starting dose?

Many people experience gastrointestinal side effects. Starting low and increasing gradually helps the body adapt, improving tolerability and long-term adherence.

4. What should I do if I feel very nauseated?

Focus on hydration and smaller, lighter meals. Avoid lying down after eating. If nausea is severe, persistent, or you cannot keep fluids down, contact your healthcare professional promptly.

5. Can I eat normally while using semaglutide?

You can usually eat normally, but many people need to reduce portion size because fullness comes sooner. Choose balanced meals and avoid very large, fatty meals if they worsen symptoms.

6. Does semaglutide cause low blood sugar?

Semaglutide itself has a lower intrinsic risk of hypoglycaemia, but the risk increases when combined with other glucose-lowering medicines such as insulin or sulfonylureas. Monitoring and possible dose adjustments may be needed.

7. What if I miss a dose?

Follow the “missed dose” instructions for your specific semaglutide product. If you’re unsure, ask your pharmacist to help you interpret the guidance.

8. Are there any long-term safety concerns?

Long-term use has been studied for relevant indications. As with any medication, ongoing medical supervision is important, especially if you develop new symptoms or have significant health changes.

9. Can I drink alcohol?

Many people choose moderate alcohol intake. However, alcohol can increase the risk of stomach upset and can affect blood sugar. If you have diabetes or take other medicines, discuss safe drinking with your healthcare professional.

10. Is semaglutide suitable for everyone?

Suitability depends on your medical history, current medicines, and the specific product indication. People with certain conditions or higher risk factors may need additional caution or alternative options.

Note: This information is general and intended to help you understand semaglutide. It does not replace individual medical advice. Always read your specific product’s instructions and consult a healthcare professional for guidance tailored to you.